These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30068257)

  • 21. Does co-morbid depression impact diabetes related costs? Evidence from a cross-sectional survey in a low-income country.
    Chereches RM; Litan CM; Zlati AM; Bloom JR
    J Ment Health Policy Econ; 2012 Sep; 15(3):127-38. PubMed ID: 23001281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy.
    Barquera S; Campos-Nonato I; Aguilar-Salinas C; Lopez-Ridaura R; Arredondo A; Rivera-Dommarco J
    Global Health; 2013 Feb; 9():3. PubMed ID: 23374611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic burden of diabetic patients in India: A review.
    Bansode B; Jungari DS
    Diabetes Metab Syndr; 2019; 13(4):2469-2472. PubMed ID: 31405662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Economic Costs of Diabetes in the U.S. in 2017.
    American Diabetes Association
    Diabetes Care; 2018 May; 41(5):917-928. PubMed ID: 29567642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Direct and indirect diabetes costs in the world].
    Logminiene Z; Norkus A; Valius L
    Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthcare Costs in Older Adults with Diabetes Mellitus: Challenges for Health Systems and for Society.
    Arredondo A; Aviles R
    J Am Geriatr Soc; 2015 Nov; 63(11):2421-3. PubMed ID: 26603071
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent trends for the management of hypertension in older adults in Latin America in the context of universal coverage: Evidence from Mexico.
    Arredondo A; Recamán AL; Suarez-Herrera JC; Cuadra SM
    Int J Health Plann Manage; 2021 Mar; 36(2):579-586. PubMed ID: 33368667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa.
    Mendis S; Chestnov O
    Prog Cardiovasc Dis; 2013; 56(3):314-21. PubMed ID: 24267438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of health systems on diabetes care in low and lower middle income countries.
    Beran D
    Curr Diab Rep; 2015 Apr; 15(4):20. PubMed ID: 25721248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Projecting diabetes prevalence among Mexicans aged 50 years and older: the Future Elderly Model-Mexico (FEM-Mexico).
    Gonzalez-Gonzalez C; Tysinger B; Goldman DP; Wong R
    BMJ Open; 2017 Oct; 7(10):e017330. PubMed ID: 29074514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003].
    Arredondo A
    Rev Invest Clin; 2001; 53(5):422-9. PubMed ID: 11795108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic Impact of Diabetes in Africa.
    Mapa-Tassou C; Katte JC; Mba Maadjhou C; Mbanya JC
    Curr Diab Rep; 2019 Jan; 19(2):5. PubMed ID: 30680578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach.
    Marcellusi A; Viti R; Mecozzi A; Mennini FS
    Eur J Health Econ; 2016 Mar; 17(2):139-47. PubMed ID: 25427540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy.
    Caporale JE; Elgart JF; Gagliardino JJ
    Global Health; 2013 Oct; 9():54. PubMed ID: 24168330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The costs of diabetes among Australians aged 45-64 years from 2015 to 2030: projections of lost productive life years (PLYs), lost personal income, lost taxation revenue, extra welfare payments and lost gross domestic product from Health&WealthMOD2030.
    Schofield D; Shrestha RN; Cunich MM; Passey ME; Veerman L; Tanton R; Kelly SJ
    BMJ Open; 2017 Jan; 7(1):e013158. PubMed ID: 28069621
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.